Acquisition: Jagsonpal Pharmaceuticals acquires Yash Pharma's India, Bhutan business,

Jagsonpal Pharmaceuticals has announced the acquisition of Yash Pharma's businesses in India and Bhutan through Growthally Advisors. This strategic move aims to broaden Jagsonpal's therapeutic footprint and bolster its market standing. \r

With Jagsonpal's 60-year legacy in gynaecology and orthopaedics complemented by Yash Pharma's 33 strong brands in dermatology and paediatrics, the acquisition diversifies Jagsonpal's product portfolio significantly. It also opens doors to a lucrative market segment valued at ₹220,000 crore (Source: IQVIA), offering substantial growth prospects.\r

According to Jagsonpal's spokesperson, this acquisition aligns perfectly with their growth strategy, enhancing their market position by tapping into new customer segments. The partnership underscores Growthally Advisors' role in facilitating mutually beneficial collaborations that drive growth in India's pharmaceutical sector.